» Articles » PMID: 23506120

Increased Levels of Inosine in a Mouse Model of Inflammation

Overview
Specialty Toxicology
Date 2013 Mar 20
PMID 23506120
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

One possible mechanism linking inflammation with cancer involves the generation of reactive oxygen, nitrogen, and halogen species by activated macrophages and neutrophils infiltrating sites of infection or tissue damage, with these chemical mediators causing damage that ultimately leads to cell death and mutation. To determine the most biologically deleterious chemistries of inflammation, we previously assessed products across the spectrum of DNA damage arising in inflamed tissues in the SJL mouse model nitric oxide overproduction ( Pang et al. ( 2007 ) Carcinogenesis 28 , 1807 - 1813 ). Among the anticipated DNA damage chemistries, we observed significant changes only in lipid peroxidation-derived etheno adducts. We have now developed an isotope-dilution, liquid chromatography-coupled, tandem quadrupole mass spectrometric method to quantify representative species across the spectrum of RNA damage products predicted to arise at sites of inflammation, including nucleobase deamination (xanthosine and inosine), oxidation (8-oxoguanosine), and alkylation (1,N(6)-ethenoadenosine). Application of the method to the liver, spleen, and kidney from the SJL mouse model revealed generally higher levels of oxidative background RNA damage than was observed in DNA in control mice. However, compared to control mice, RcsX treatment to induce nitric oxide overproduction resulted in significant increases only in inosine and only in the spleen. Further, the nitric oxide synthase inhibitor, N-methylarginine, did not significantly affect the levels of inosine in control and RcsX-treated mice. The differences between DNA and RNA damage in the same animal model of inflammation point to possible influences from DNA repair, RcsX-induced alterations in adenosine deaminase activity, and differential accessibility of DNA and RNA to reactive oxygen and nitrogen species as determinants of nucleic acid damage during inflammation.

Citing Articles

Ribonucleosides from tRNA in hyperglycemic mammalian cells and diabetic murine cardiac models.

Dodson T, Nieuwoudt S, Morse C, Pierre V, Liu C, Senyo S Life Sci. 2023; 318:121462.

PMID: 36736767 PMC: 9992345. DOI: 10.1016/j.lfs.2023.121462.


Effects of Acute 2,3,7,8-Tetrachlorodibenzo-p-Dioxin Exposure on the Circulating and Cecal Metabolome Profile.

Dopkins N, Neameh W, Hall A, Lai Y, Rutkovsky A, Gandy A Int J Mol Sci. 2021; 22(21).

PMID: 34769237 PMC: 8583798. DOI: 10.3390/ijms222111801.


Direct Immunodetection of Global A-to-I RNA Editing Activity with a Chemiluminescent Bioassay.

Knutson S, Arthur R, Johnston H, Heemstra J Angew Chem Int Ed Engl. 2021; 60(31):17009-17017.

PMID: 33979483 PMC: 8562906. DOI: 10.1002/anie.202102762.


Inosine in Biology and Disease.

Srinivasan S, Torres A, Ribas de Pouplana L Genes (Basel). 2021; 12(4).

PMID: 33921764 PMC: 8072771. DOI: 10.3390/genes12040600.


Translesion synthesis by AMV, HIV, and MMLVreverse transcriptases using RNA templates containing inosine, guanosine, and their 8-oxo-7,8-dihydropurine derivatives.

Glennon M, Skinner A, Krutsinger M, Resendiz M PLoS One. 2020; 15(8):e0235102.

PMID: 32857764 PMC: 7455023. DOI: 10.1371/journal.pone.0235102.


References
1.
Nishikura K . Functions and regulation of RNA editing by ADAR deaminases. Annu Rev Biochem. 2010; 79:321-49. PMC: 2953425. DOI: 10.1146/annurev-biochem-060208-105251. View

2.
Gal A, Tamir S, Tannenbaum S, Wogan G . Nitric oxide production in SJL mice bearing the RcsX lymphoma: a model for in vivo toxicological evaluation of NO. Proc Natl Acad Sci U S A. 1996; 93(21):11499-503. PMC: 38086. DOI: 10.1073/pnas.93.21.11499. View

3.
Dong M, Wang C, Deen W, Dedon P . Absence of 2'-deoxyoxanosine and presence of abasic sites in DNA exposed to nitric oxide at controlled physiological concentrations. Chem Res Toxicol. 2003; 16(9):1044-55. DOI: 10.1021/tx034046s. View

4.
Tong Y, Lo Y . Diagnostic developments involving cell-free (circulating) nucleic acids. Clin Chim Acta. 2005; 363(1-2):187-96. DOI: 10.1016/j.cccn.2005.05.048. View

5.
Kleinert H, Pautz A, Linker K, Schwarz P . Regulation of the expression of inducible nitric oxide synthase. Eur J Pharmacol. 2004; 500(1-3):255-66. DOI: 10.1016/j.ejphar.2004.07.030. View